Topic: Study of Gemzar and Mistletoe

National Cancer Institute:   Special Category:  NIH Clinical Center trial is conducting a Phase I trial:
Gemcitabine combined with Mistletoe in treating patients with advanced Solid Tumor.

Trial Lead Organization:
National Center for Complementary and Alternative Medicine

e-mail: manskyp@mail.nih.gov

Trial Site:
Maryland, Bethesda

Warren Grant Magnuson Clinical Center
Patient Recruitment:   Ph.  800-411-1222

Criteria include the following:
No CNS matastases
No previous mistletoe or gemcitabine

THIS INFORMATION IS NOT INTENDED NOR IMPLIED TO BE A SUBSTITUTE FOR PROFESSIONAL MEDICAL ADVICE. YOU SHOULD ALWAYS SEEK THE ADVICE OF YOUR PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROVIDER